Celaid Therapeutics is a biotechnology company focused on using hematopoietic stem cells for next-generation medical applications. It has developed methods to expand these cells in vitro, enabling large-scale production for treatments targeting leukemia, lymphoma, anemia, and genetic disorders.
Founded
2020
Total Funding
$1M+
Total Rounds
2
First Raise
Oct 7, 2025
Latest Raise
Oct 5, 2026
New funding rounds in your inbox every week · No noise, all Signal.
Founders and leadership hierarchy for this company.
| Date | Deal Type | Amount | Lead Investor |
|---|---|---|---|
| 10/5/2026 | |||
1 more funding round available
Upgrade to Premium to view all historical funding rounds
Upgrade to Premium to view Capital Momentum Score and performance metrics
New funding rounds in your inbox every week · Free